Dr. Gimire is an Associate Clinical Professor at the University of California, San Francisco-Fresno. He will take us on a deep dive into Chronic Hypersensitivity Pneumonitis (CHP), and discuss the epidemiology of HP, the principles of management, and what the future holds.
Developed by the California Thoracic Society in collaboration with Boehringer Ingelheim Pharmaceuticals, Inc.
[ Ссылка ]
0:00 Introduction
1:10 Definition
1:36 Subtypes
2:46 Pathogenesis
7:02 Inciting Agents & Common Diseases
7:38 Genetic Susceptibility
9:22 Epidemiology
13:38 Exposure Assessment Tools - Expert opinion
17:57 HRCT - non fibrotic HP
18:47 HRCT - fibrotic CHP
19:26 HRCT-three density pattern
20:11 Bronchoscopy
23:06 Histopathology - fibrotic HP
24:37 Differentiating fibrotic CHP from IPF
26:00 Molecular Biomarkers
26:55 Diagnostic Approach
28:02 Diagnosis - Multidisciplinary discussion
28:32 Prognostic Factors
29:55 Principles of Management
32:23 Pharmacotherapy
36:30 Non-pharmacological treatments
